Monday, March 26, 2012

Breast Cancer Gene Case to be Reconsidered

Last week I wrote about Mayo v. Prometheus, a Supreme Court case involving the patentability of medical diagnostic processes.  In that post I predicted that the Supreme Court would tell the lower courts to reconsider another pending case involving the patenting of genes used to detect breast cancer, Association for Molecular Pathology v. Myriad Genetics, to apply the legal principles in the Mayo opinion.   That has in fact happened, according to the second page of today's Supreme Court order list.

No comments:

Post a Comment